DK1861073T3 - Fremgangsmåde til fremstilling af calcium-kompositioner i en kontinuerlig fluid-bed - Google Patents

Fremgangsmåde til fremstilling af calcium-kompositioner i en kontinuerlig fluid-bed

Info

Publication number
DK1861073T3
DK1861073T3 DK06710498T DK06710498T DK1861073T3 DK 1861073 T3 DK1861073 T3 DK 1861073T3 DK 06710498 T DK06710498 T DK 06710498T DK 06710498 T DK06710498 T DK 06710498T DK 1861073 T3 DK1861073 T3 DK 1861073T3
Authority
DK
Denmark
Prior art keywords
fluid bed
continuous fluid
preparing calcium
calcium compositions
calcium
Prior art date
Application number
DK06710498T
Other languages
English (en)
Other versions
DK1861073T4 (da
Inventor
Jan Yngvar Piene
Kjell Tomas Lunde
Original Assignee
Nycomed Pharma As
Nycomed Danmark Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36808838&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1861073(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Pharma As, Nycomed Danmark Aps filed Critical Nycomed Pharma As
Publication of DK1861073T3 publication Critical patent/DK1861073T3/da
Application granted granted Critical
Publication of DK1861073T4 publication Critical patent/DK1861073T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Dental Preparations (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Drying Of Solid Materials (AREA)
DK06710498.4T 2005-03-04 2006-03-06 Fremgangsmåde til fremstilling af calciumsammensætninger i en kontinuerlig fluid bed DK1861073T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200500334 2005-03-04
PCT/IB2006/000474 WO2006092727A2 (en) 2005-03-04 2006-03-06 Process for the production of calcium compositions in a continuous fluid bed

Publications (2)

Publication Number Publication Date
DK1861073T3 true DK1861073T3 (da) 2009-06-15
DK1861073T4 DK1861073T4 (da) 2012-07-23

Family

ID=36808838

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06710498.4T DK1861073T4 (da) 2005-03-04 2006-03-06 Fremgangsmåde til fremstilling af calciumsammensætninger i en kontinuerlig fluid bed

Country Status (20)

Country Link
US (1) US20110142928A1 (da)
EP (1) EP1861073B8 (da)
JP (2) JP5190273B2 (da)
CN (1) CN101132774A (da)
AT (1) ATE430559T1 (da)
AU (1) AU2006219583B2 (da)
BR (1) BRPI0607693B8 (da)
CA (1) CA2599312C (da)
DE (1) DE602006006658D1 (da)
DK (1) DK1861073T4 (da)
EA (1) EA011379B1 (da)
ES (1) ES2324957T5 (da)
IL (1) IL185325A (da)
MX (1) MX2007010519A (da)
NZ (1) NZ560534A (da)
PL (1) PL1861073T5 (da)
PT (1) PT1861073E (da)
UA (1) UA93502C2 (da)
WO (1) WO2006092727A2 (da)
ZA (1) ZA200706879B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8859011B2 (en) 2006-05-12 2014-10-14 Particle Dynamics International, Llc Calcium compositions
JP2010533667A (ja) * 2007-07-19 2010-10-28 ディーエスエム アイピー アセッツ ビー．ブイ． 錠剤化可能な親油性健康成分の配合物
DE102008051572A1 (de) * 2008-09-05 2010-03-11 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Herstellung von Phosphatbindern und auf diese Weise hergestellte Phosphatbinder
US9510617B2 (en) * 2012-04-13 2016-12-06 Frito-Lay North America, Inc. Micropellets of fine particle nutrients and methods of incorporating same into snack food products
US8431155B1 (en) 2012-04-30 2013-04-30 Veroscience Llc Bromocriptine formulations
US9271523B2 (en) 2012-05-23 2016-03-01 Dennis Williams Rotor assembly with one-piece finger member
CN103344093A (zh) * 2013-06-09 2013-10-09 山东奥诺能源科技有限公司 一种立式连续流化床造粒干燥装置及方法
WO2015020191A1 (ja) * 2013-08-09 2015-02-12 日東薬品工業株式会社 カルシウム剤
US10503156B2 (en) * 2015-09-18 2019-12-10 Fisher-Rosemount Systems, Inc. Methods and apparatus to define stages for multi-variate batch control analytics
RU2616399C1 (ru) * 2015-11-17 2017-04-14 Владимир Владимирович Колесник Способ получения биологически активного продукта для адаптивного питания и биологически активный продукт для адаптивного питания
CN107772478A (zh) * 2016-08-24 2018-03-09 南京逐陆医药科技有限公司 一种复合维生素片及其制备方法
CN108261396B (zh) * 2016-12-30 2021-12-24 北京化工大学 一种制粒方法
US20220323360A1 (en) * 2019-09-06 2022-10-13 Novo Nordisk A/S Method and equipment for fractionation of granules for use in pharmaceutical compositions
CN113679675B (zh) * 2021-09-10 2023-04-07 新疆特丰药业股份有限公司 一种钙颗粒剂及其制备方法和用途
CN114129521A (zh) * 2021-11-05 2022-03-04 昆明源瑞制药有限公司 一种碳酸钙d3颗粒剂及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6197068A (ja) * 1984-10-17 1986-05-15 Okawara Mfg Co Ltd 連続流動層造粒装置における噴霧装置への粉粒体の付着防止方法
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
CA1279574C (en) * 1985-04-17 1991-01-29 Jeffrey L. Finnan Process for lubricating water-soluble vitamin powders
JPS62282629A (ja) * 1986-05-30 1987-12-08 Okawara Mfg Co Ltd 連続式流動層造粒装置
JP2566146B2 (ja) * 1987-08-20 1996-12-25 株式会社大川原製作所 連続式流動層造粒装置
DE4006734C1 (da) † 1990-03-03 1991-07-25 Benckiser-Knapsack Gmbh, 6802 Ladenburg, De
ES2066092T3 (es) * 1990-11-29 1995-03-01 Wei Ming Pharmaceutical Mfg Co Coadyuvante para la formacion directa de comprimidos.
US5965162A (en) * 1993-09-10 1999-10-12 Fuisz Technologies Ltd. Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom
FR2717387B1 (fr) * 1994-03-17 1996-10-18 Hi Pharmtech Procédé de fabrication de comprimés à croquer à base de troxérutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine d'amoxicilline.
FR2724844B1 (fr) * 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
DE19617487A1 (de) * 1996-05-02 1997-11-06 Merck Patent Gmbh Geschmacksverbesserung von Arzneimittelwirkstoffen
US5939091A (en) * 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
GB0003782D0 (en) * 2000-02-17 2000-04-05 Dumex Ltd As Process
DK1126017T3 (da) * 2000-02-18 2006-02-06 Glatt Ingtech Gmbh Fremgangsmåde til fremstilling af höjeffektive vaskemidler og komponenter i höjeffektive vaskemidler
AR028064A1 (es) * 2000-05-03 2003-04-23 Omnia Fertilizer Ltd Metodo para producir granulos de nitrato de calcio
CZ20023626A3 (cs) * 2000-05-04 2003-06-18 Dsm N. V. Způsob výroby granulí enzymu za použití fluidní vrstvy
US6499984B1 (en) * 2000-05-22 2002-12-31 Warner-Lambert Company Continuous production of pharmaceutical granulation
CN1494419A (zh) * 2001-03-06 2004-05-05 协和发酵工业株式会社 口腔内快速崩解制剂
WO2005115342A1 (en) * 2004-05-24 2005-12-08 Nycomed Pharma As Particulate comprising a calcium-containing compound and a sugar alcohol

Also Published As

Publication number Publication date
BRPI0607693A2 (pt) 2010-03-16
UA93502C2 (uk) 2011-02-25
IL185325A (en) 2014-04-30
BRPI0607693B8 (pt) 2021-05-25
JP5190273B2 (ja) 2013-04-24
EP1861073A2 (en) 2007-12-05
EP1861073B8 (en) 2014-06-04
NZ560534A (en) 2009-09-25
PL1861073T3 (pl) 2009-10-30
US20110142928A1 (en) 2011-06-16
DK1861073T4 (da) 2012-07-23
ATE430559T1 (de) 2009-05-15
EA011379B1 (ru) 2009-02-27
PT1861073E (pt) 2009-06-08
PL1861073T5 (pl) 2012-09-28
JP2008531678A (ja) 2008-08-14
CA2599312A1 (en) 2006-09-08
WO2006092727A2 (en) 2006-09-08
CA2599312C (en) 2015-12-22
WO2006092727A3 (en) 2006-10-26
AU2006219583A1 (en) 2006-09-08
ZA200706879B (en) 2009-09-30
ES2324957T5 (es) 2012-08-21
EP1861073B2 (en) 2012-04-18
WO2006092727A9 (en) 2006-12-14
CN101132774A (zh) 2008-02-27
JP2013082688A (ja) 2013-05-09
MX2007010519A (es) 2008-01-18
DE602006006658D1 (de) 2009-06-18
EP1861073B1 (en) 2009-05-06
EA200701886A1 (ru) 2008-02-28
BRPI0607693B1 (pt) 2019-04-16
ES2324957T3 (es) 2009-08-20
AU2006219583B2 (en) 2011-11-10
IL185325A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
DK1861073T3 (da) Fremgangsmåde til fremstilling af calcium-kompositioner i en kontinuerlig fluid-bed
CY1126116T1 (el) Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη
RS50812B (sr) Suva granulisana kompozicija koja sadrži emtricitabin i tenofovir df
SG152240A1 (en) Pharmaceutical compositions comprising an amphiphilic starch
IL177087A0 (en) Controlled-release pharmaceutical composition and method for producing the same
SI1896364T1 (sl) Praĺ kasti apneni sestavek, postopek za proizvodnjo in uporaba le-tega
SG170087A1 (en) Pharmaceutical compositions
JO2578B1 (en) Compounds Theophene benzimidazole
CY1118180T1 (el) Μεθοδος για παρασκευη στερεας φαρμακευτικης συνθεσης
WO2007075847A3 (en) Glucokinase activators
TW200716605A (en) 2,6-quinolinyl derivatives, processes for preparing them and their uses
EP1962838A4 (en) Farnesoid X RECEPTOR AGONISTS
MA28550B1 (fr) Composes et procedes permettant de traiter la dyslipidemie
AP2003002916A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
HK1118798A1 (en) Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof -n-
PL1888514T3 (pl) Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych
TWI315305B (en) Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof
WO2006060384A3 (en) Formulations of substituted benzoxazoles
WO2006060542A3 (en) Formulations of substituted benzoxazoles
IL181022A0 (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
WO2008101173A3 (en) Biodegradable compositions and materials
TW200638932A (en) CCI-779 polymorph and use thereof
DK1345594T3 (da) Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradin
UA87692C2 (ru) Фармацевтическая композиция, содержащая рисперидон и распадающаяся при пероральном приеме
CY1108916T1 (el) Υποκαθιστουμενες πυρρολες, οι ενωσεις που τις περιεχουν, διαδικασια παρασκευης και χρηση τους